Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Pancreatic Cancer · Pancreatic Neoplasms · Pancreatic Ductal Adenocarcinoma · Advanced Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Changhai Hospital, Shanghai, China
Contact: Principal Investigator (Gang Jin, Doctor)